Granted Korean Patent for its MyoVista® Wavelet Technology Southlake, Texas, Feb. 03, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused…
To see the video, follow the link: https://proactiveinvestors.com/companies/news/1004693/heartsciences-using-technology-to-help-make-lifesaving-ecg-s-better-using-artificial-intelligence-1004693.html?viewSource=SkyAlphabet
Southlake, Texas, Jan. 20, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also…
Southlake, TX, Jan. 04, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also…
Patient Enrollment Close to Completion and Continue to Target FDA De Novo Resubmission Around Current Fiscal Year End Southlake, Texas, Dec. 16, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS;…
Source: Getty Images By Shania Kennedy December 05, 2022 - Rutgers University and medical technology company HeartSciences announced a multi-year collaboration agreement to develop artificial intelligence (AI)-based electrocardiogram (ECG) algorithms and expand the clinical value…
